157 related articles for article (PubMed ID: 11303779)
1. VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury.
Sigalov E; Fridkin M; Brenneman DE; Gozes I
J Mol Neurosci; 2000 Dec; 15(3):147-54. PubMed ID: 11303779
[TBL] [Abstract][Full Text] [Related]
2. VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.
Steingart RA; Solomon B; Brenneman DE; Fridkin M; Gozes I
J Mol Neurosci; 2000 Dec; 15(3):137-45. PubMed ID: 11303778
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I
Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133
[TBL] [Abstract][Full Text] [Related]
4. From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division.
Gozes I; Divinsky I; Pilzer I; Fridkin M; Brenneman DE; Spier AD
J Mol Neurosci; 2003; 20(3):315-22. PubMed ID: 14501014
[TBL] [Abstract][Full Text] [Related]
5. SNV, a lipophilic superactive VIP analog, acts through cGMP to promote neuronal survival.
Ashur-Fabian O; Perl O; Lilling G; Fridkin M; Gozes I
Peptides; 1999; 20(5):629-33. PubMed ID: 10465516
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
Zusev M; Gozes I
Regul Pept; 2004 Dec; 123(1-3):33-41. PubMed ID: 15518891
[TBL] [Abstract][Full Text] [Related]
7. A novel VIP responsive gene. Activity dependent neuroprotective protein.
Gozes I; Zamostiano R; Pinhasov A; Bassan M; Giladi E; Steingart RA; Brenneman DE
Ann N Y Acad Sci; 2000; 921():115-8. PubMed ID: 11193814
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats.
Yang J; Song TB; Zhao ZH; Qiu SD; Hu XD; Chang L
Brain Res; 2011 Jun; 1398():94-101. PubMed ID: 21620378
[TBL] [Abstract][Full Text] [Related]
9. Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress.
Steingart RA; Gozes I
Mol Cell Endocrinol; 2006 Jun; 252(1-2):148-53. PubMed ID: 16704895
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of the peptides ADNF-9 and NAP on hypoxic-ischemic brain injury in neonatal rats.
Kumral A; Yesilirmak DC; Sonmez U; Baskin H; Tugyan K; Yilmaz O; Genc S; Gokmen N; Genc K; Duman N; Ozkan H
Brain Res; 2006 Oct; 1115(1):169-78. PubMed ID: 16938277
[TBL] [Abstract][Full Text] [Related]
11. [Neuroprotective effects of vasoactive intestinal peptide against rat cerebral ischemia].
Yang J; Zhao ZH; Qian YH; Hu XD; Li M; Zong CH
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1801-4. PubMed ID: 18158987
[TBL] [Abstract][Full Text] [Related]
12. The anti-inflammatory peptide stearyl-norleucine-VIP delays disease onset and extends survival in a rat model of inherited amyotrophic lateral sclerosis.
Goursaud S; Schäfer S; Dumont AO; Vergouts M; Gallo A; Desmet N; Deumens R; Hermans E
Exp Neurol; 2015 Jan; 263():91-101. PubMed ID: 25311268
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
14. Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage.
Zhao J; Li L; Ling C; Li J; Pang JY; Lin YC; Liu J; Huang R; Wang GL; Pei Z; Zeng J
Brain Res; 2009 Dec; 1302():240-7. PubMed ID: 19765563
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells.
Sperling O; Bromberg Y; Oelsner H; Zoref-Shani E
Neurosci Lett; 2003 Nov; 351(3):137-40. PubMed ID: 14623125
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide and related molecules induce nitrite accumulation in the extracellular milieu of rat cerebral cortical cultures.
Ashur-Fabian O; Giladi E; Furman S; Steingart RA; Wollman Y; Fridkin M; Brenneman DE; Gozes I
Neurosci Lett; 2001 Jul; 307(3):167-70. PubMed ID: 11438390
[TBL] [Abstract][Full Text] [Related]
17. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment.
Lönngren U; Näpänkangas U; Lafuente M; Mayor S; Lindqvist N; Vidal-Sanz M; Hallböök F
Brain Res Bull; 2006 Dec; 71(1-3):208-18. PubMed ID: 17113948
[TBL] [Abstract][Full Text] [Related]
18. Activity-dependent neuroprotective protein: from gene to drug candidate.
Gozes I
Pharmacol Ther; 2007 May; 114(2):146-54. PubMed ID: 17363064
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain.
Gressens P; Marret S; Hill JM; Brenneman DE; Gozes I; Fridkin M; Evrard P
J Clin Invest; 1997 Jul; 100(2):390-7. PubMed ID: 9218516
[TBL] [Abstract][Full Text] [Related]
20. Protection against developmental deficiencies by a lipophilic VIP analogue.
Gozes I; Bachar M; Bardea A; Davidson A; Rubinraut S; Fridkin M
Neurochem Res; 1998 May; 23(5):689-93. PubMed ID: 9566607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
